LifeTech Scientific Corporation

As of December 31, 2025, LifeTech Scientific Corporation carries a market capitalization of 6.87B, placing it among publicly traded companies globally. Its enterprise value stands at 5.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

LifeTech Scientific Corporation's next confirmed earnings release is scheduled for March 31, 2027.

As of December 31, 2025, LifeTech Scientific Corporation has 4.40B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, LifeTech Scientific Corporation maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, LifeTech Scientific Corporation's stock has declined approximately 28.30% over the past 52 weeks. The 50-day moving average sits at 1.38, while the 200-day moving average is 1.61.

As of December 31, 2025, LifeTech Scientific Corporation holds 1.28B in cash and equivalents against 8.94M in total debt, resulting in a net debt position of -800.52M. Total book value stands at 3.91B, with working capital of 941.20M providing operational flexibility.

LifeTech Scientific Corporation's most recent stock split took place on January 26, 2015 with a 1:8 split ratio.